» Articles » PMID: 28815212

Variable Virulence of Biotype 3 Due to MARTX Toxin Effector Domain Composition

Overview
Journal mSphere
Date 2017 Aug 18
PMID 28815212
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

is an environmental organism that causes septic human infections characterized by high morbidity and mortality. The annual incidence and global distribution of this pathogen are increasing as ocean waters warm. Clinical strains exhibit variations in the primary virulence toxin, suggesting a potential for the emergence of new strains with altered virulence properties. A clonal outbreak of tilapia-associated wound infections in Israel serves as a natural experiment for the sudden emergence of a new strain. The effector domain content of the multifunctional autoprocessing RTX (MARTX) toxin of the outbreak-associated biotype 3 (BT3) strains was previously shown to harbor a modification generated by recombination. The modification introduced an actin-induced adenylate cyclase effector domain (ExoY) and an effector domain that disrupts the Golgi organelle (DmX). Here, we report that the exchange of these effector domains for a putative progenitor biotype 1 toxin arrangement produces a toxin that slows the lysis kinetics of targeted epithelial cells but increases cellular rounding phenotypes in response to bacteria. In addition, replacing the biotype 3 toxin variant with the putative progenitor biotype 1 variant renders the resulting strain significantly more virulent in mice. This suggests that the exchange of MARTX effector domains during the emergence of BT3 generated a toxin with reduced toxin potency, resulting in decreased virulence of this outbreak-associated strain. We posit that selection for reduced virulence may serve as a route for this lethal infectious agent to enter the human food chain by allowing it to persist in natural hosts. is a serious infection linked to climate change. The virulence capacity of these bacteria can vary by gene exchange, resulting in new variants of the primary virulence toxin. In this study, we tested whether the emergence of an epidemic strain of with a novel toxin variant correlated with a change in virulence. We found that restoring the biotype 3 toxin variant to the putative progenitor-type toxin resulted in dramatically increased virulence, revealing that the emergence of the biotype 3 strain could be linked to virulence reduction. This reduced virulence, previously found also in the biotype 1 strain, suggests that reduced virulence may stimulate outbreaks, as strains have greater capacity to enter the human food chain through reduced impact to environmental hosts.

Citing Articles

Dissemination of pathogenic bacteria is reinforced by a MARTX toxin effector duet.

Choi S, Lee Y, Park S, Jang S, Park J, Oh D Nat Commun. 2024; 15(1):6218.

PMID: 39043696 PMC: 11266601. DOI: 10.1038/s41467-024-50650-0.


-infecting bacteriophages and their potential to control biofilm.

Cevallos-Urena A, Kim J, Kim B Food Sci Biotechnol. 2023; 32(12):1719-1727.

PMID: 37780594 PMC: 10533469. DOI: 10.1007/s10068-023-01361-7.


Genetic Divergence of Vibrio vulnificus Clinical Isolates with Mild to Severe Outcomes.

Kling K, Trinh S, Leyn S, Rodionov D, Rodionov I, Herrera A mBio. 2022; 13(5):e0150022.

PMID: 36169197 PMC: 9600620. DOI: 10.1128/mbio.01500-22.


Vibrio vulnificus PlpA facilitates necrotic host cell death induced by the pore forming MARTX toxin.

Cho C, Choi S, Kim M, Kim B J Microbiol. 2022; 60(2):224-233.

PMID: 35102528 DOI: 10.1007/s12275-022-1448-x.


Factors That Influence Climate Change-Related Mortality in the United States: An Integrative Review.

McDermott-Levy R, Scolio M, Shakya K, Moore C Int J Environ Res Public Health. 2021; 18(15).

PMID: 34360518 PMC: 8345936. DOI: 10.3390/ijerph18158220.


References
1.
Jones M, Oliver J . Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009; 77(5):1723-33. PMC: 2681776. DOI: 10.1128/IAI.01046-08. View

2.
Amaro C, Biosca E . Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans. Appl Environ Microbiol. 1996; 62(4):1454-7. PMC: 167917. DOI: 10.1128/aem.62.4.1454-1457.1996. View

3.
Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L . Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet. 1999; 354(9188):1421-4. DOI: 10.1016/s0140-6736(99)02471-x. View

4.
Belyy A, Raoux-Barbot D, Saveanu C, Namane A, Ogryzko V, Worpenberg L . Actin activates Pseudomonas aeruginosa ExoY nucleotidyl cyclase toxin and ExoY-like effector domains from MARTX toxins. Nat Commun. 2016; 7:13582. PMC: 5150216. DOI: 10.1038/ncomms13582. View

5.
Zaidenstein R, Sadik C, Lerner L, Valinsky L, Kopelowitz J, Yishai R . Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel. Emerg Infect Dis. 2008; 14(12):1875-82. PMC: 2634625. DOI: 10.3201/eid1412.080499. View